Letter: treatment with subcutaneous CT‐P13 in Crohn’s disease patients with intravenous infliximab failure - Université de Lorraine Access content directly
Journal Articles Alimentary Pharmacology & Therapeutics (Suppl) Year : 2022

Dates and versions

hal-04168061 , version 1 (21-07-2023)

Identifiers

Cite

Bénédicte Caron, Mathurin Fumery, Patrick Netter, Laurent Peyrin-Biroulet. Letter: treatment with subcutaneous CT‐P13 in Crohn’s disease patients with intravenous infliximab failure. Alimentary Pharmacology & Therapeutics (Suppl), 2022, 55 (4), pp.508-509. ⟨10.1111/apt.16770⟩. ⟨hal-04168061⟩
34 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More